Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study
2006

Understanding Apoptosis Induced by Docetaxel in Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Fabbri Francesco, Carloni Silvia, Brigliadori Giovanni, Zoli Wainer, Lapalombella Rosa, Marini Marina

Primary Institution: Department of Medical Oncology, Morgagni-Pierantoni Hospital; Department of Histology, Embryology and Applied Biology, University of Bologna

Hypothesis

The study aims to determine the temporal succession of the main events that characterise taxane-induced apoptosis in a cancer cell line.

Conclusion

The study suggests a sequence of apoptotic events over time, with the collapse of mitochondrial transmembrane potential being the earliest sign of apoptosis.

Supporting Evidence

  • Docetaxel induced mitochondrial membrane transition and cell shrinkage within a few hours.
  • Cell cycle was almost completely blocked in G2/M phase within 24 hours after treatment.
  • DNA fragmentation was detected by TUNEL assay after 48 hours of treatment.
  • A very similar time-course of apoptotic events was found in a myelomonocytic cell line treated with the same drug.

Takeaway

When cancer cells are treated with a drug called docetaxel, they go through a series of changes that lead to their death, starting with changes in their energy-producing parts.

Methodology

The study used cytometric methods to evaluate biochemical and cytological modifications in bladder cancer cells treated with docetaxel.

Limitations

The study acknowledges limitations in cytometric methods, including sensitivity and variability in drug response within an asynchronous cell population.

Digital Object Identifier (DOI)

10.1186/1471-2121-7-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication